Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial
Tap, William D, Dr, Jones, Robin L, MD, Van Tine, Brian A, MD, Chmielowski, Bartosz, MD, Elias, Anthony D, Prof, Adkins, Douglas, Prof, Agulnik, Mark, MD, Cooney, Matthew M, MD, Livingston, Michael B, MD, Pennock, Gregory, MD, Hameed, Meera R, MD, Shah, Gaurav D, MD, Qin, Amy, PhD, Shahir, Ashwin, MD, Cronier, Damien M, PhD, Ilaria, Robert, MD, Conti, Ilaria, MD, Cosaert, Jan, MD, Schwartz, Gary K, Prof
Published in The Lancet (British edition) (30.07.2016)
Published in The Lancet (British edition) (30.07.2016)
Get full text
Journal Article
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients
Pearson, Andrew D.J., Rossig, Claudia, Lesa, Giovanni, Diede, Scott J., Weiner, Susan, Anderson, John, Gray, Juliet, Geoerger, Birgit, Minard-Colin, Veronique, Marshall, Lynley V., Smith, Malcolm, Sondel, Paul, Bajars, Marcis, Baldazzi, Claudia, Barry, Elly, Blackman, Sam, Blanc, Patricia, Capdeville, Renaud, Caron, Hubert, Cole, Peter D., Jiménez, Jorge Camarero, Demolis, Pierre, Donoghue, Martha, Elgadi, Mabrouck, Gajewski, Thomas, Galluzzo, Sara, Ilaria, Robert, Jenkner, Alessandro, Karres, Dominik, Kieran, Mark, Ligas, Franca, Lowy, Israel, Meyers, Michael, Oprea, Corina, Peddareddigari, Vijay G.R., Sterba, Jaroslav, Stockman, Paul K., Suenaert, Peter, Tabori, Uri, van Tilburg, Cornelis, Yancey, Todd, Weigel, Brenda, Norga, Koenraad, Reaman, Gregory, Vassal, Gilles
Published in European journal of cancer (1990) (01.03.2020)
Published in European journal of cancer (1990) (01.03.2020)
Get full text
Journal Article
Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells results in EWS/FLI-1-dependent, ewing sarcoma-like tumors
CASTILLERO-TREJO, Yeny, ELIAZER, Susan, LILIN XIANG, RICHARDSON, James A, ILARIA, Robert L
Published in Cancer research (Chicago, Ill.) (01.10.2005)
Published in Cancer research (Chicago, Ill.) (01.10.2005)
Get full text
Journal Article
Population Pharmacokinetic Modeling of Olaratumab, an Anti-PDGFRα Human Monoclonal Antibody, in Patients with Advanced and/or Metastatic Cancer
Mo, Gary, Baldwin, John R., Luffer-Atlas, Debra, Ilaria, Robert L., Conti, Ilaria, Heathman, Michael, Cronier, Damien M.
Published in Clinical pharmacokinetics (01.03.2018)
Published in Clinical pharmacokinetics (01.03.2018)
Get full text
Journal Article
Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer
McGuire, William P, Penson, Richard T, Gore, Martin, Herraez, Antonio Casado, Peterson, Patrick, Shahir, Ashwin, Ilaria, Jr, Robert
Published in BMC cancer (27.12.2018)
Published in BMC cancer (27.12.2018)
Get full text
Journal Article
A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia
Vadhan-Raj, Saroj, Abonour, Rafat, Goldman, Jonathan W, Smith, David A, Slapak, Christopher A, Ilaria, Jr, Robert L, Tiu, Ramon V, Wang, Xuejing, Callies, Sophie, Cox, Joanne, Tuttle, Jay L, Lau, Yiu-Keung, Roeland, Eric J
Published in Journal of hematology and oncology (21.03.2017)
Published in Journal of hematology and oncology (21.03.2017)
Get full text
Journal Article
Randomised phase II study of second-line olaratumab with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer
Hakenberg, Oliver W., Perez-Gracia, Jose Luis, Castellano, Daniel, Demkow, Tomasz, Ali, Tarek, Caffo, Orazio, Heidenreich, Axel, Schultze-Seemann, Wolfgang, Sautois, Brieuc, Pavlik, Ivan, Qin, Amy, Novosiadly, Ruslan D., Shahir, Ashwin, Ilaria, Robert, Nippgen, Johannes
Published in European journal of cancer (1990) (01.01.2019)
Published in European journal of cancer (1990) (01.01.2019)
Get full text
Journal Article
Web Resource
Exposure–response relationship of olaratumab for survival outcomes and safety when combined with doxorubicin in patients with soft tissue sarcoma
Jones, Robin L., Mo, Gary, Baldwin, John R., Peterson, Patrick M., Ilaria, Robert L., Conti, Ilaria, Cronier, Damien M., Tap, William D.
Published in Cancer chemotherapy and pharmacology (01.01.2019)
Published in Cancer chemotherapy and pharmacology (01.01.2019)
Get full text
Journal Article
Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, immune activation and extracellular matrix reorganization in the tumor microenvironment
O'Connell, Brenda C, Hubbard, Charley, Zizlsperger, Nora, Fitzgerald, Donna, Kutok, Jeffrey L, Varner, Judith, Ilaria, Robert, Cobleigh, Melody A, Juric, Dejan, Tkaczuk, Kate H R, Elias, Anthony, Lee, Arielle, Dakhil, Shaker, Hamilton, Erika, Soliman, Hatem, Peluso, Stephane
Published in Journal for immunotherapy of cancer (30.08.2024)
Published in Journal for immunotherapy of cancer (30.08.2024)
Get full text
Journal Article
Imatinib Mesylate Inhibits Antigen-Specific Memory CD8 T Cell Responses In Vivo
Sinai, Parisa, Berg, Rance E, Haynie, J. Marshall, Egorin, Merrill J, Ilaria, Robert L., Jr, Forman, James
Published in Journal of Immunology (15.02.2007)
Published in Journal of Immunology (15.02.2007)
Get full text
Journal Article
A phase 2 study of tasisulam sodium (LY573636 sodium) as second‐line treatment for patients with unresectable or metastatic melanoma
Kirkwood, John M., Gonzalez, Rene, Reintgen, Douglas, Clingan, Philip R., McWilliams, Robert R., de Alwis, Dinesh P., Zimmermann, Annamaria, Brown, Michael P., Ilaria, Robert L., Millward, Michael J.
Published in Cancer (15.10.2011)
Published in Cancer (15.10.2011)
Get full text
Journal Article
The CNS is a sanctuary for leukemic cells in mice receiving imatinib mesylate for Bcr/Abl-induced leukemia
Wolff, Nicholas C., Richardson, James A., Egorin, Merrill, Ilaria, Robert L.
Published in Blood (15.06.2003)
Published in Blood (15.06.2003)
Get full text
Journal Article
PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia
Wolff, Nicholas C., Veach, Darren R., Tong, William P., Bornmann, William G., Clarkson, Bayard, Ilaria, Robert L.
Published in Blood (15.05.2005)
Published in Blood (15.05.2005)
Get full text
Journal Article
Imatinib Mesylate Efficiently Achieves Therapeutic Intratumor Concentrations in Vivo but Has Limited Activity in a Xenograft Model of Small Cell Lung Cancer
WOLFF, Nicholas C, RANDLE, Dwight E, EGORIN, Merrill J, MINNA, John D, ILARIA, Robert L
Published in Clinical cancer research (15.05.2004)
Published in Clinical cancer research (15.05.2004)
Get full text
Journal Article
A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors
Simon, George R., Ilaria, Robert L., Sovak, Mika A., Williams, Charles C., Haura, Eric B., Cleverly, Ann L., Sykes, Amanda K., Wagner, Margaret M., de Alwis, Dinesh P., Slapak, Christopher A., Miller, Mary A., Spriggs, David R.
Published in Cancer chemotherapy and pharmacology (01.11.2011)
Published in Cancer chemotherapy and pharmacology (01.11.2011)
Get full text
Journal Article